Scientists test new pill version of popular drug
NCT ID NCT05784402
Summary
This study tested a new tablet version of the medicine semaglutide in healthy volunteers. The main goal was to measure how much of the drug gets into the blood from the new tablet and compare it to an older tablet version. About 260 healthy participants took different doses of the tablets over several weeks so researchers could track the drug levels in their blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Altasciences Clinical Company, Inc
Montreal, Quebec, H3P 3P1, Canada
-
Altasciences Clinical Kansas, Inc.
Kansas City, Kansas, 66212, United States
-
Altasciences Clinical LA, Inc.
Cypress, California, 90630, United States
Conditions
Explore the condition pages connected to this study.